234 related articles for article (PubMed ID: 33864499)
1. Proteolysis and inflammation of the kidney glomerulus.
Demir F; Troldborg A; Thiel S; Lassé M; Huesgen PF; Tomas NM; Wiech T; Rinschen MM
Cell Tissue Res; 2021 Aug; 385(2):489-500. PubMed ID: 33864499
[TBL] [Abstract][Full Text] [Related]
2. The role of the alternative pathway of complement activation in glomerular diseases.
Łukawska E; Polcyn-Adamczak M; Niemir ZI
Clin Exp Med; 2018 Aug; 18(3):297-318. PubMed ID: 29450785
[TBL] [Abstract][Full Text] [Related]
3. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis.
Gonzalo-Gil E; García-Herrero C; Toldos O; Usategui A; Criado G; Pérez-Yagüe S; Barber DF; Pablos JL; Galindo M
Front Immunol; 2018; 9():1948. PubMed ID: 30210500
[No Abstract] [Full Text] [Related]
4. No complement receptor 1 stumps on podocytes in human glomerulopathies.
Moll S; Miot S; Sadallah S; Gudat F; Mihatsch MJ; Schifferli JA
Kidney Int; 2001 Jan; 59(1):160-8. PubMed ID: 11135068
[TBL] [Abstract][Full Text] [Related]
5. Complement catalyzing glomerular diseases.
Zipfel PF; Wiech T; Gröne HJ; Skerka C
Cell Tissue Res; 2021 Aug; 385(2):355-370. PubMed ID: 34613485
[TBL] [Abstract][Full Text] [Related]
6. Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response.
Papadimitraki ED; Tzardi M; Bertsias G; Sotsiou E; Boumpas DT
Lupus; 2009 Aug; 18(9):831-5. PubMed ID: 19578108
[TBL] [Abstract][Full Text] [Related]
7. The podocyte protease web: uncovering the gatekeepers of glomerular disease.
Rinschen MM; Huesgen PF; Koch RE
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1812-F1816. PubMed ID: 30230368
[TBL] [Abstract][Full Text] [Related]
8. CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patients.
Teixeira JE; Costa RS; Lachmann PJ; Würzner R; Barbosa JE
Clin Exp Immunol; 1996 Sep; 105(3):497-503. PubMed ID: 8809140
[TBL] [Abstract][Full Text] [Related]
9. Interstitial inflammatory and chronic tubulointerstitial lesions in lupus nephritis: comparison with those in IgA nephropathy.
Yamamoto T; Nagase M; Hishida A; Honda N
Lupus; 1993 Aug; 2(4):261-8. PubMed ID: 8268975
[TBL] [Abstract][Full Text] [Related]
10. Pathological spectrum of glomerular disease in patients with renal insufficiency: a single-center study in Northeastern China.
Chen L; Luodelete M; Dong C; Li B; Zhang W; Nie P; Liu J; Chen X; Luo P
Ren Fail; 2019 Nov; 41(1):473-480. PubMed ID: 31198075
[No Abstract] [Full Text] [Related]
11. Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis.
Wada Y; Iyoda M; Suzuki T; Tachibana S; Kanazawa N; Matsumoto K; Honda H
Virchows Arch; 2021 Nov; 479(5):997-1005. PubMed ID: 34302213
[TBL] [Abstract][Full Text] [Related]
12. The Metalloproteinase ADAMTS5 Is Expressed by Interstitial Inflammatory Cells in IgA Nephropathy and Is Proteolytically Active on the Kidney Matrix.
Taylor S; Whitfield M; Barratt J; Didangelos A
J Immunol; 2020 Oct; 205(8):2243-2254. PubMed ID: 32917786
[TBL] [Abstract][Full Text] [Related]
13. Advances in the pathology of glomerular diseases.
Weening JJ; Ronco P; Remuzzi G
Contrib Nephrol; 2013; 181():12-21. PubMed ID: 23689563
[TBL] [Abstract][Full Text] [Related]
14. Complement in glomerular diseases.
Tan Y; Zhao MH
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():11-15. PubMed ID: 30298653
[TBL] [Abstract][Full Text] [Related]
15. Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist.
Itto R; Oe Y; Imaruoka K; Sato E; Sekimoto A; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N
Tohoku J Exp Med; 2019 Oct; 249(2):127-133. PubMed ID: 31666446
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.
Kim MK; Maeng YI; Lee SJ; Lee IH; Bae J; Kang YN; Park BT; Park KK
Int J Clin Exp Pathol; 2013; 6(10):2157-67. PubMed ID: 24133594
[TBL] [Abstract][Full Text] [Related]
17. N-Degradomic Analysis Reveals a Proteolytic Network Processing the Podocyte Cytoskeleton.
Rinschen MM; Hoppe AK; Grahammer F; Kann M; Völker LA; Schurek EM; Binz J; Höhne M; Demir F; Malisic M; Huber TB; Kurschat C; Kizhakkedathu JN; Schermer B; Huesgen PF; Benzing T
J Am Soc Nephrol; 2017 Oct; 28(10):2867-2878. PubMed ID: 28724775
[TBL] [Abstract][Full Text] [Related]
18. Fn14 in podocytes and proteinuric kidney disease.
Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing C1q nephropathy from lupus nephritis.
Sharman A; Furness P; Feehally J
Nephrol Dial Transplant; 2004 Jun; 19(6):1420-6. PubMed ID: 15004260
[TBL] [Abstract][Full Text] [Related]
20. Complement-mediated cellular injury.
Takano T; Elimam H; Cybulsky AV
Semin Nephrol; 2013 Nov; 33(6):586-601. PubMed ID: 24161043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
